Phase 2 study of bevacizumab plus erloti
โ
Philip A. Philip; Michelle R. Mahoney; Kyle D. Holen; Donald W. Northfelt; Henry
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 825 KB